文献速递肝病

α-1抗胰蛋白酶缺乏症:一种重新浮现的成人肝脏疾病

Alpha-1 antitrypsin deficiency: A re-surfacing adult liver disorder.
PubMed 文献 · J Hepatol · 2021-11-27

本文综述α-1抗胰蛋白酶缺乏症(AATD)的基因型相关肝脏表型与疾病易感性、肝病发生机制及促进因素、肝纤维化评估方法,并讨论这一常被忽视疾病的诊断与治疗新进展。

要点

  • AATD由SERPINA1基因突变导致α-1抗胰蛋白酶在肝细胞内质网潴留,引起蛋白毒性肝损伤和功能丧失性肺病。
  • 纯合Pi∗Z突变(Pi∗ZZ基因型)导致大多数严重AATD病例,可诱发儿童和成人肝病。
  • 杂合Pi∗Z突变(Pi∗MZ基因型)是已确定的肝病遗传修饰因素。

核心结论

  • 本文综述AATD的基因型相关肝脏表型与疾病易感性、肝病发生机制及促进因素、肝纤维化评估方法,并讨论新兴诊断与治疗手段。

研究设计与样本

  • 综述,检索范围未在摘要中报告。

主要发现

  • 纯合Pi∗Z突变(Pi∗ZZ基因型)导致大多数严重AATD病例,可诱发儿童和成人肝病。
  • 杂合Pi∗Z突变(Pi∗MZ基因型)是已确定的肝病遗传修饰因素。
  • AATD因α-1抗胰蛋白酶在肝细胞内质网潴留引起蛋白毒性肝损伤,并导致功能丧失性肺病。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Alpha-1 antitrypsin deficiency (AATD) arises from mutations in the SERPINA1 gene encoding alpha-1 antitrypsin (AAT) that lead to AAT retention in the endoplasmic reticulum of hepatocytes, causing proteotoxic liver injury and loss-of-function lung disease. The homozygous Pi∗Z mutation (Pi∗ZZ genotype) is responsible for the majority of severe AATD cases and can precipitate both paediatric and adult liver diseases, while the heterozygous Pi∗Z mutation (Pi∗MZ genotype) is an established genetic modifier of liver disease. We review genotype-related hepatic phenotypes/disease predispositions. We also describe the mechanisms and factors promoting the development of liver disease, as well as approaches to evaluate the extent of liver fibrosis. Finally, we discuss emerging diagnostic and therapeutic approaches for the clinical management of this often neglected disorder.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Fromme M, Schneider CV, Trautwein C, et al. Alpha-1 antitrypsin deficiency: A re-surfacing adult liver disorder. J Hepatol. 2021. PMID: 34848258. doi:10.1016/j.jhep.2021.11.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。